Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

BACKGROUND: Although programmed cell death-1/programmed death-ligand 1 (PD-L1) inhibitors show remarkable antitumor activity, a large portion of patients with cancer, even those with high PD-L1-expressing tumors, do not respond to their effects. Most PD-L1 inhibitors contain modified fragment crysta...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ji-Eun, Kim, Seong-Eun, Keam, Bhumsuk, Park, Ha-Ram, Kim, Soyeon, Kim, Miso, Kim, Tae Min, Doh, Junsang, Kim, Dong-Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445348/
https://www.ncbi.nlm.nih.gov/pubmed/32830112
http://dx.doi.org/10.1136/jitc-2020-000873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445348/
https://www.ncbi.nlm.nih.gov/pubmed/32830112
http://dx.doi.org/10.1136/jitc-2020-000873

Ejemplares similares